INTRODUCTION
During IVF the inability to recover oocytes from mature follicles, previously described as the empty follicle syndrome (EFS), is currently believed to result from inadequate exposure to hCG. While this is often due to a technical problem with hCG administration, abnormal bioactivity or rapid plasma clearance of certain hCG batches has been implicated in this condition. With recent publications (1, 2) suggesting an incidence of 0.5-0.6% it is likely that most ART programs will face this situation at some point. In this report, we discuss two cases recently encountered in our program and offer practical guidelines for management.
CASE REPORTS
Both patients were scheduled for IVF/ICSI for male factor infertility. They underwent GnRHa down-regulation, FSH stimulation, and were given 10,000 IU of hCG IM by their husbands. In Case 1, the patient was a 39-year-old woman on her first ART cycle. The hCG was given with 11 follicles present. Seven follicles were >14 mm, with the leading three >18 mm. Follicle aspiration was performed 35 h after hCG, but failed to yield oocytes despite repeated flushing of all of the 11 follicles present. Although the patient and her husband confirmed that hCG was given exactly as instructed, serum β-hCG was undetectable. A repeat injection of 10,000 IU of hCG was given that evening. At follicle aspiration 35 h later, only hemorrhagic fluid, without oocytes, was recovered from collapsed follicles. Serum β-hCG was 141 mIU/mL at that time. In her subsequent IVF cycle, 3 months later, 10 follicles yielded seven oocytes resulting in four embryos. No pregnancy was established in the fresh cycle.
In Case 2, the patient was a 40-year-old woman undergoing her third IVF cycle. She had previously conceived on her second IVF attempt. Follicle aspiration was performed 35 h after hCG was given. The hCG had been given with a total of 21 follicles present on transvaginal sonography, with 11 follicles >14 mm and the leading 5 follicles ≥18 mm. After failing to retrieve oocytes from six mature-appearing follicles in one ovary and two in the other, a catheterized urine specimen was obtained, which showed a negative pregnancy test. The procedure was interrupted leaving several follicles intact because our experience, supported by published reports (3), suggests that β-hCG levels should exceed 100 mIU/mL, which is above the threshold of urine pregnancy tests. Therefore, the patient was awakened from sedation. She admitted that some solution may have leaked between the syringe and needle during hCG administration. The serum β-hCG was 2.9 mIU/mL, and progesterone 0.9 ng/mL. The hCG injection was repeated that evening. Thirtyfive hours later, 10 Metaphase II oocytes were recovered from intact follicles. None were retrieved from previously punctured follicles despite repeated flushing. ICSI yielded nine embryos. On Day 5, two fully expanded blastocysts were transferred and five were frozen. Although no pregnancy resulted from the fresh ET, the patient conceived from the thaw ET and delivered a healthy nine pound boy at 39 weeks of gestation. Coulam et al., in 1986 (4) , introduced EFS into the medical literature. The initial reports which followed did not shed much light on the etiology of this condition. More recently, the literature from the 1990s strongly suggests that the failure to retrieve oocytes from mature-appearing follicles is a sporadic phenomenon, primarily caused by lack of hCG effect in a particular cycle, without the tendency for recurrence (3, 5) . Indeed, both of our patients had eggs retrieved in previous or future cycles. Although in most of the studies the situation can be explained by a technical problem with the hCG administration (e.g., poor timing or improper injection technique as in Case 2), some report empty follicles despite accurately timed injections administered by a medical professional (3).
DISCUSSION
The common denominator in the majority of the cases reported is the absence of detectable serum β-hCG on the day of retrieval. Zegers-Hochschild et al. (5) , showed absent serum β-hCG 12 h after IM injection in EFS cycles compared to a mean of 207.5 mIU/mL in controls. Both hCG batches had similar biological activity on rat Leydig cell preparations. However, when 5,000 IU hCG were injected intravenously into male volunteers, the EFS batches showed no detectable levels 10 min later. Injections from control batches resulted in serum levels of nearly 3,000 mIU/mL at 10 min. The authors concluded that EFS may result from rapid plasma clearance of hCG because of the high affinity of liver cells for certain abnormal batches. Ndukwe et al. (3) , showed that serum β-hCG levels ranged from 106 to 290 mIU/mL (mean 209) 36 h after hCG injection in women with successful oocyte retrieval. This compares to a range of 0 to 9 mIU/mL (mean 4) in EFS patients. They suggested that retrievals be interrupted, and a β-hCG level checked if no oocytes are recovered from all follicles on one ovary. This leaves the other ovary intact for a successful retrieval after a second injection of hCG. In the two cases we report, we were unable to recover any oocytes from the follicles that had been previously punctured despite repeated flushing while the yield from intact follicles was excellent. Our experience suggests that when the first few follicles fail to yield oocytes, a urine pregnancy test should be promptly performed and the retrieval discontinued while awaiting confirmation of suboptimal levels on a blood test. This avoids aspiration and vigorous repeated flushing of all follicles in a desperate attempt to recover an egg when the absence of hCG has prevented the loosening of the oocyte-cumulus complex from the follicle wall.
Occasionally, as reported by Hassan et al. (6) and Awonuga et al. (2) , eggs are not recovered despite the presence of adequate serum β-hCG levels (range 145-377). In these reports, a successful oocyte retrieval was achieved 24 h later, after a second hCG injection. Assuming that the patients described in these studies had taken their hCG injection 35 h prior to the first retrieval (as opposed to the night before retrieval), we believe that these instances represent unusual exceptions. As a general rule, finding no eggs in the initial few follicles does not warrant interrupting the retrieval as long as satisfactory levels of β-hCG are present. This will avoid premature discontinuation of procedures where, for no obvious reason, no oocytes are found in the first few follicles, yet an adequate number of oocytes is obtained from the subsequent follicles.
INTRODUCTION
Gonadotropin-releasing hormone (GnRH) agonists are routinely used in in vitro fertilisation (IVF) treatment to prevent premature luteinisation. The incidence of cycle cancellation due to premature luteinisation is approximately 2%. Well documented
